New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Rapid tissue donation program offers feasible approach to improve research

Rapid tissue donation program offers feasible approach to improve research

byH. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainPrecision medicine with targeted therapies has led to improved treatment options and patient outcomes. These appro
World medicine December 22,2023
Rapid tissue donation program offers feasible approach to improve research

Rapid tissue donation program offers feasible approach to improve research

byH. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainPrecision medicine with targeted therapies has led to improved treatment options and patient outcomes. These appro
World medicine December 22,2023
Scientists identify potential drug target for BRCA-mutated tumours

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e
Oncology December 22,2023
Scientists identify potential drug target for BRCA-mutated tumours

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e
Oncology December 22,2023
Artificial intelligence tracks down leukemia

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli
Oncology December 22,2023
Artificial intelligence tracks down leukemia

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli
Oncology December 22,2023
CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainA comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 g
Oncology December 22,2023
CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainA comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 g
Oncology December 22,2023
Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

byDartmouth-Hitchcock Medical CenterLipoprotein Lipase facilitates binding of very low density lipoprotein particles (red) to breast cancer cells (blue cell nuclei). Credit: William Kinlaw, III,
Oncology December 22,2023
Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

byDartmouth-Hitchcock Medical CenterLipoprotein Lipase facilitates binding of very low density lipoprotein particles (red) to breast cancer cells (blue cell nuclei). Credit: William Kinlaw, III,
Oncology December 22,2023
Structural analysis reveals an unexpected mechanism for a cancer drug

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p
Oncology December 22,2023
Structural analysis reveals an unexpected mechanism for a cancer drug

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p
Oncology December 22,2023
Diagnostic test helps find bloodstream infections before they appear

Diagnostic test helps find bloodstream infections before they appear

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainA test called microbial cell-free DNA identified potentially lethal bloodstream infections in children with relapsed leukemia
Public Health & Prevention December 22,2023
Diagnostic test helps find bloodstream infections before they appear

Diagnostic test helps find bloodstream infections before they appear

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainA test called microbial cell-free DNA identified potentially lethal bloodstream infections in children with relapsed leukemia
Public Health & Prevention December 22,2023
Lack of self-exams hampers early melanoma identification

Lack of self-exams hampers early melanoma identification

(HealthDay)—The biggest obstacle to early detection and treatment of melanoma among residents of rural, frontier communities is a chronic lack of skin self-examination (SSE), according to a study rece
Oncology December 22,2023
Lack of self-exams hampers early melanoma identification

Lack of self-exams hampers early melanoma identification

(HealthDay)—The biggest obstacle to early detection and treatment of melanoma among residents of rural, frontier communities is a chronic lack of skin self-examination (SSE), according to a study rece
Oncology December 22,2023
Patient-reported outcomes predict aromatase inhibitor adherence

Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co
Oncology December 22,2023
Patient-reported outcomes predict aromatase inhibitor adherence

Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co
Oncology December 22,2023
Metabolic adaptation ensures survival of colon cancer cells

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to
Oncology December 22,2023
Metabolic adaptation ensures survival of colon cancer cells

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to
Oncology December 22,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com